Sanofi
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
30 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
February 5, 2018 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 31, 2022 | Bridgewater Associates, LP | 0.49% | November 2, 2022 |
| September 28, 2022 | Bridgewater Associates, LP | 0.50% | November 2, 2022 |
| September 13, 2022 | Bridgewater Associates, LP | 0.48% | September 15, 2022 |
| September 12, 2022 | Bridgewater Associates, LP | 0.50% | September 15, 2022 |
| July 26, 2022 | Bridgewater Associates, LP | 0.49% | July 28, 2022 |
| July 11, 2022 | Bridgewater Associates, LP | 0.58% | July 28, 2022 |
| July 6, 2022 | Bridgewater Associates, LP | 0.61% | July 28, 2022 |
| July 5, 2022 | Bridgewater Associates, LP | 0.59% | July 28, 2022 |
| July 1, 2022 | Bridgewater Associates, LP | 0.61% | July 28, 2022 |
| June 29, 2022 | Bridgewater Associates, LP | 0.59% | July 28, 2022 |
| June 24, 2022 | Bridgewater Associates, LP | 0.62% | July 28, 2022 |
| June 15, 2022 | Bridgewater Associates, LP | 0.53% | July 28, 2022 |
| March 23, 2020 | Bridgewater Associates, LP | 0.49% | March 25, 2020 |
| March 20, 2020 | Bridgewater Associates, LP | 0.58% | March 25, 2020 |
| March 17, 2020 | Bridgewater Associates, LP | 0.69% | March 25, 2020 |
| March 16, 2020 | Bridgewater Associates, LP | 0.79% | March 25, 2020 |
| March 12, 2020 | Bridgewater Associates, LP | 0.80% | March 25, 2020 |
| March 9, 2020 | Bridgewater Associates, LP | 0.60% | March 25, 2020 |
| April 10, 2018 | Bridgewater Associates, LP | 0.49% | April 12, 2018 |
| April 6, 2018 | Bridgewater Associates, LP | 0.56% | April 12, 2018 |
| March 23, 2018 | Bridgewater Associates, LP | 0.66% | April 12, 2018 |
| February 28, 2018 | Bridgewater Associates, LP | 0.50% | April 12, 2018 |
| February 20, 2018 | Bridgewater Associates, LP | 0.49% | February 22, 2018 |
| February 14, 2018 | Bridgewater Associates, LP | 0.58% | February 22, 2018 |
| February 12, 2018 | Bridgewater Associates, LP | 0.64% | February 22, 2018 |
| February 9, 2018 | Bridgewater Associates, LP | 0.72% | February 22, 2018 |
| February 8, 2018 | Bridgewater Associates, LP | 0.65% | February 22, 2018 |
| February 7, 2018 | Bridgewater Associates, LP | 0.59% | February 22, 2018 |
| February 6, 2018 | Bridgewater Associates, LP | 0.62% | February 22, 2018 |
| February 5, 2018 | Bridgewater Associates, LP | 0.50% | February 22, 2018 |
Other companies sold short in France
- Ubisoft Entertainment 13.90% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- Renault 6.44% of the capital sold short
- FDJ United 6.17% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.25% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Sanofi, source AMF, data as at October 31, 2022, https://www.quivad.com/action/sanofi